4
Changes in Ownership
NEKTAR THERAPEUTICS Filed Acc 0001209191-23-050223
Director sold 4,359 shares at $0.69 ($3,008)
From the SEC's structured data for this filing
Trades in this filing
Curet Myriam · Director
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2023-09-18 | Sale : show line 1 in the form | −4,359 | $0.69 | $3,008 | 27,418 | D |
| Open-market sales · 4,359 sh · avg $0.69 · $3,008 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2023-09-19 | Grant or award : show line 2 in the form Stock Option | +85,000 | 85,000 | D |
Loading xslF345X05/doc4.xml…